ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
17.01855
0.27%
Brent Oil
82.765
0.00%
Bitcoin
63,783.34
-0.17%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Autolus Therapeutics PLC (AUTL)

  7. Autolus Therapeutics PLC (AUTL) Noticias

AUTL Autolus Therapeutics PLC

4.19
0.08 (1.95%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Autolus Therapeutics PLC AUTL NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.08 1.95% 4.19 23:00:07
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.22 4.055 4.37 4.19 4.11
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202409:00GLOBEAbstract for longer-term follow-up and additional data..
23/4/202406:00GLOBEAutolus Therapeutics to Report First Quarter 2024 Financial..
02/4/202406:00GLOBEAutolus Therapeutics announces acceptance of Marketing..
01/4/202406:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
14/3/202406:00GLOBEAutolus Therapeutics Reports Full Year 2023 Financial..
12/3/202406:00GLOBEAutolus Therapeutics receives Medicines and Healthcare..
11/3/202406:00GLOBEAutolus Therapeutics announces publication in Blood Cancer..
29/2/202406:00GLOBEAutolus Therapeutics to Report Full Year 2023 Financial..
23/2/202416:28EDGAR2Form D - Notice of Exempt Offering of Securities
22/2/202406:00GLOBEAutolus Therapeutics announces publication in Nature..
21/2/202416:01EDGAR2Form SC 13D - General statement of acquisition of beneficial..
14/2/202407:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202416:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202415:17EDGAR2Form 8-K - Current report
08/2/202406:00GLOBEAutolus Announces Pricing of Underwritten Offering
08/2/202405:06EDGAR2Form 8-K - Current report
08/2/202404:45GLOBEBioNTech and Autolus Announce Strategic CAR-T Cell Therapy..
07/2/202421:00EDGAR2Form S-3ASR - Automatic shelf registration statement of..
31/1/202415:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/1/202412:02EDGAR2Form 8-K - Current report
23/1/202406:00GLOBEAutolus Therapeutics announces publication in ACS Chemical..
22/1/202406:54DJNAutolus Therapeutics Gets BLA Acceptance for Obecabtagene..
22/1/202406:00GLOBEAutolus Therapeutics announces acceptance of Biologics..
10/1/202414:12EDGAR2Form 8-K - Current report
10/1/202406:00GLOBEAutolus Therapeutics announces the appointment of Robert W...
22/12/202307:24EDGAR2Form 8-K - Current report
22/12/202306:00GLOBEAutolus Therapeutics Announces Changes to its Board of..
11/12/202307:31EDGAR2Form 8-K - Current report
09/12/202319:30GLOBEAutolus Therapeutics Presents Clinical Data Updates at the..
28/11/202313:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27/11/202306:54DJNAutolus Seeks FDA OK of Obe-Cel in Adult B-Cell Acute..
27/11/202306:07EDGAR2Form 8-K - Current report
27/11/202306:00GLOBEAutolus Therapeutics Submits Biologics License Application..
15/11/202306:00GLOBEAutolus Therapeutics to Host Analyst / Investor event at the..
09/11/202315:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:18EDGAR2Form 8-K - Current report
06/11/202306:00GLOBEAutolus Therapeutics announces participation in upcoming..
03/11/202315:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/11/202315:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202308:00GLOBEAutolus Therapeutics to Present Clinical Data Updates at the..
02/11/202306:11GLOBEAutolus Therapeutics Reports Third Quarter 2023 Financial..
17/10/202306:00GLOBEAutolus Therapeutics to host virtual event to discuss the..
11/10/202307:07GLOBECorrection - Autolus Therapeutics to report third quarter..
11/10/202306:00GLOBEAutolus Therapeutics to report third quarter 2023 financial..
05/9/202306:00GLOBEAutolus Therapeutics announces data from AUTO1/22 trial in..
07/8/202315:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/8/202315:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/8/202306:00GLOBEAutolus Therapeutics Reports Second Quarter 2023 Financial..
21/7/202315:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/7/202306:00GLOBEAutolus Therapeutics to report second quarter 2023 financial..

Su Consulta Reciente

NASDAQ
AUTL
Autolus Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados